Innovative Smartphone App Demonstrates Success in Detecting Heart Attacks and Strokes During Clinical Trials

A new smartphone app called ECHAS has demonstrated high accuracy and speed in detecting heart attacks and strokes during clinical trials, showing promise for improving emergency response and saving lives.
A groundbreaking smartphone application designed to rapidly identify signs of heart attacks and strokes has shown promising results in a recent clinical trial. Developed collaboratively by experts from UVA Health, Harvard, Northeastern, and other premier institutions, the app—known as ECHAS (Emergency Call for Heart Attack and Stroke)—aims to empower individuals to recognize critical symptoms promptly and seek immediate medical care.
The initial study involved over 200 patients from emergency rooms who used the app after their stabilization. The participants, with an average age of 62, included both stroke and heart attack cases. Remarkably, the app successfully identified all patients who required hospitalization or emergency evaluation. It demonstrated a 'high sensitivity' for detecting emergencies and proved to be fast — detecting strokes in under two minutes and heart attacks in just a minute.
This tool asks users a series of medically based questions similar to those asked at hospital intake and incorporates a finger-tapping test designed to detect physical weakness indicative of a stroke or heart attack. Based on the responses and test results, the app calculates a risk score and provides guidance on whether to call emergency services, contact a hotline, or consult a healthcare provider.
Rapid diagnosis is crucial in these emergencies, as the 'golden hour'—the first 60 minutes after symptom onset—is when treatments are most effective. Delays often lead to severe outcomes, including death or lasting disabilities. Many individuals hesitate to seek help due to uncertainty, which the ECHAS app aims to address by providing immediate, accessible assessment.
The researchers are optimistic about the app's potential to save lives and reduce delays in emergency response. While not yet publicly available, further trials are planned, including a partnership with UVA’s Center for Telehealth. The goal is for people worldwide to use this technology to improve emergency response times and outcomes.
The study and its findings were published in the journal JMIR Formative Research, highlighting the app’s accuracy and speed in real-world settings. Experts believe this innovation has the potential to revolutionize how we approach urgent neurological and cardiovascular care, especially in situations where every second counts.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Deep Tissue Cancer Treatment with Cold Plasma Technology
Innovative research shows that cold plasma can penetrate deep into tissue layers to target and destroy cancer cells, offering new hope for advanced cancer therapies.
New Genetic Marker Enhances Survival Rates in Ovarian and Other Cancers with Immunotherapy
A new genetic mutation in PPP2R1A has been linked to improved survival outcomes in ovarian and other cancers treated with immunotherapy, opening new pathways for personalized cancer therapies.
New Immunotherapy Approved in England for Severe Birch Pollen Allergies in Hay Fever Patients
A new immunotherapy treatment for severe birch pollen allergies has been approved in England, offering hope for better management of hay fever symptoms by training the immune system to build tolerance.
Public Health Research Highlights Vaccines' Role in Preventing Childhood Hearing Loss
Recent studies suggest that vaccines play a crucial role in preventing hearing loss in children, highlighting the need for broader immunization efforts and further research. Learn how vaccination can help protect auditory health worldwide.